Want to join the conversation?
Biotechnology company $AMGN announced detailed phase 2 results of erenumab drug that showed a significant reduction in monthly migraine days compared with placebo in patients with chronic migraine. This data will be presented at the 5th European Headache and Migraine Trust International Congress (EHMTIC) in Glasgow, Scotland.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.